Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Study of TJ033721 in Subjects With Advanced or Metastatic Solid Tumors

Phase I

This is an open label, multi-center, multiple dose Phase 1 study to evaluate the safety, tolerability, MTD PK, and PD of TJ033721 in subjects with advanced or metastatic solid tumors.
Phase I
I
Das, Satya
NCT04900818
VICCPHI2151

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: